NASDAQ: HCACHall Chadwick Acquisition Corp Stock
$9.95+0.00 (+0%)
Updated Apr 27, 2026
HCAC Price
$9.95
Fair Value Price
N/A
Market Cap
$290.54M
52 Week Low
$9.91
52 Week High
$10.14
P/E
124.38x
P/B
-42.85x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$652.92k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.23
Operating Cash Flow
-$195k
Beta
0.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HCAC Overview
A blank-check company formed to effect a merger, share exchange, asset acquisition, share purchase or similar business combination. The company expects to focus on technology, critical materials and energy sectors.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HCAC's potential to beat the market
- HCAC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
HCAC
RankedUnranked of 36
RankedUnranked of 36
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.54 | C | |
| $11.15 | C | |
| $10.02 | C |
Be the first to know about important HCAC news, forecast changes, insider trades & much more!
HCAC News
Overview
Due Diligence Score
–
Industry Average (10)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HCAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HCAC is poor value based on its earnings relative to its share price (124.38x), compared to the US market average (35x)
P/E vs Market Valuation
HCAC is good value based on its earnings relative to its share price (124.38x), compared to the US Shell Companies industry average (-57.31x)
P/E vs Industry Valuation
HCAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more HCAC due diligence checks available for Premium users.
Valuation
HCAC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
124.38x
Industry
-57.31x
Market
35x
HCAC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HCAC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
HCAC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-42.85x
Industry
30.33x
HCAC's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
HCAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$208.6M
Liabilities
$8.3M
Debt to equity
-1.23
HCAC's short-term assets ($710.68k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HCAC's long-term liabilities ($8.28M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HCAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HCAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
HCAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HCAC vs Shell Company Stocks
Hall Chadwick Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.